Petra Leiding

Petra Leiding has extensive work experience in the pharmaceutical industry. Petra currently holds the position of Chief Analytics Officer at ANESTPHARMA since July 2022. Prior to this, they worked at HELM AG, where they held the roles of Director Strategic Initiatives and Head of Department Market Intelligence. Before that, they were the Head of Business Insights & Analytics at Teva Pharmaceuticals and held various positions at AstraZeneca, including Director Reimbursement Analysis and Business Intelligence Manager. Petra also has experience in research, having worked as a Research Director for Pharma and Finance at InMoment and as a Senior Research Executive at TNS Infratest.

Petra Leiding's education history includes the following:

- From 1991 to 1993, they attended RWTH Aachen University and completed their Vordiplom in Biology/biological sciences.

- From 1993 to 1996, they studied at Universität Witten/Herdecke, earning a Diplom in Biochemistry and Molecular Biology.

- Between 1997 and 2000, Petra pursued their education at the Max Planck Institute for Evolutionary Biology, where they achieved a Dr. rer. nat. degree. The field of study for this degree is not specified.

- Finally, from 2004 to 2007, they attended Euro-FH Europäische Fernhochschule Hamburg and obtained an MBA in economics.

No additional assumptions or information can be made about Petra Leiding's education history outside of the provided chronological details.